查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948216

2026年全球智慧切片檢查設備市場報告

Smart Biopsy Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，智慧切片檢查設備的市場規模顯著成長，預計2025年將達到30.1億美元，到2026年將達到32.3億美元，複合年成長率為7.2%。過去幾年的成長可歸因於癌症發病率的上升、微創診斷程序的廣泛應用、先進診斷成像基礎設施的擴展、核心針穿刺活體組織切片技術的日益普及以及臨床醫生在影像引導診斷方面培訓的加強。

預計未來幾年智慧切片檢查設備市場規模將強勁成長，2030年將達到43.2億美元，複合年成長率（CAGR）為7.6%。預測期內的成長將主要受以下因素驅動：對精準癌症診斷的需求不斷成長、對智慧外科技術的投資增加、機器人輔助介入平台的擴展、對早期疾病檢測的日益重視以及人工智慧驅動的診斷支持的日益普及。預測期內的關鍵趨勢包括：影像引導切片檢查系統的日益普及、機器人輔助切片檢查手術的日益廣泛應用、即時組織反饋技術的日益融合、微創診斷技術的擴展以及對診斷準確性和患者安全性的日益關注。

微創手術的普及預計將顯著推動智慧切片檢查設備市場的成長。微創手術旨在最大程度地減少對正常身體結構的影響，而智慧切片檢查設備的應用則能提高組織取樣的精準度和準確性。這些設備通常整合了先進的成像技術，例如即時超音波和磁振造影（MRI）引導，使醫務人員能夠透過更小的切口精準定位切片檢查區域。這不僅減輕了患者的不適感，也提高了診斷的準確性。例如，根據美國整形外科醫師協會（ASPS）—一家總部位於美國的專業醫療協會—在2024年6月發布的公告，預計2023年微創手​​術的成長率將達到7%，比外科手術的成長率高出2%。神經調節劑注射和透明質酸填充劑注射的案例分別超過900萬例和500萬例。因此，微創手術的日益普及是推動智慧切片檢查設備市場成長的主要動力。

智慧切片檢查設備市場的主要企業正致力於開發先進的技術創新，例如多重模式乳房切片標記物，以提高病灶定位的準確性，保持長期的病灶位置可見性，並增強診斷信心。多重模式標記物是專門設計的切片檢查部位標記物，可在超音波、乳房X光攝影和磁振造影掃描中保持清晰可見，使臨床醫生能夠準確追蹤切片檢查部位並支持精準的後續觀察評估。例如，2024年3月，總部位於美國的醫療科技公司Mamotome推出了其獲得510(k)已經過核准的下一代多重模式乳房切片部位標記物LumiMARK。此標記物有三種3D形狀可供選擇，包括Tulip™和Rose™，可確保在各種成像模式下保持一致的可見性，並提高乳房組織和淋巴結中的長期可檢測性，從而支持更準確的診斷和持續的臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球智慧切片檢查設備市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
  • 主要趨勢
    • 影像導引切片檢查系統的應用日益普及
    • 機器人輔助切片檢查手術的使用日益增多
    • 即時組織回饋技術整合的進展
    • 微創診斷技術的擴展
    • 更重視診斷準確性與病人安全

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷和影像中心
  • 學術研究機構
  • 腫瘤診所
  • 門診手術中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球智慧切片檢查設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球智慧切片檢查設備市場規模、對比及成長率分析
  • 全球智慧切片檢查設備市場表現：規模與成長，2020-2025年
  • 全球智慧切片檢查設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球總潛在市場（TAM）

第9章 市場細分

  • 依產品
  • 針刺切片檢查器械，立體定位導絲
  • 透過引導技術
  • 超音波引導切片檢查、立體定位引導切片檢查、磁振造影引導切片檢查等引導技術
  • 透過使用
  • 乳癌、皮膚癌、肝癌、攝護腺癌及其他用途
  • 最終用戶
  • 醫院、學術研究機構、診斷與影像中心
  • 按類型細分：針刺切片檢查裝置
  • 核心針切片裝置、細針穿刺（FNA）裝置、真空輔助切片檢查裝置
  • 按類型細分：定位線
  • 鉤線定位裝置、雷達定位裝置、磁性定位裝置

第10章 區域與國家分析

  • 全球智慧切片檢查設備市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球智慧切片檢查設備市場：依國家/地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 智慧切片檢查設備市場：競爭格局及市場佔有率（2024年）
  • 智慧切片檢查設備市場：公司估值矩陣
  • 智慧切片檢查設備市場：公司概況
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Hologic Inc.
    • Cook Medical Inc.
    • Medtronic Plc

第37章：其他領先和創新企業

  • Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe BV, INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年智慧切片檢查設備市場：提供新機會的國家
  • 2030年智慧切片檢查設備市場：充滿新機會的細分市場
  • 智慧切片檢查設備市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MSBDI01_G26Q1

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

Tariffs are impacting the smart biopsy devices market by increasing costs of imported imaging components, robotic actuators, precision needles, sensors, and control software used in advanced biopsy systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-precision medical components, while Asia-Pacific faces higher system integration costs. These tariffs are raising capital expenditure requirements and slowing procurement cycles. However, they are also encouraging localized manufacturing, regional supplier partnerships, and domestic innovation in smart diagnostic device development.

The smart biopsy devices market research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including smart biopsy devices industry global market size, regional shares, competitors with a smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $3.01 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising cancer incidence rates, increased use of minimally invasive diagnostic procedures, expansion of advanced imaging infrastructure, growing adoption of core needle biopsy techniques, improved clinician training in image-guided diagnostics.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising investments in smart surgical technologies, expansion of robotic-assisted intervention platforms, growing focus on early disease detection, increasing integration of AI-driven diagnostic support. Major trends in the forecast period include increasing adoption of image-guided biopsy systems, rising use of robotic-assisted biopsy procedures, growing integration of real-time tissue feedback technologies, expansion of minimally invasive diagnostic techniques, enhanced focus on diagnostic accuracy and patient safety.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. FFor instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, minimally invasive procedures grew by 7 percent in 2023, surpassing the growth of surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid filler treatments reaching over 9 million and 5 million, respectively. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy devices market are focusing on developing advanced innovations, such as multi-modality breast biopsy markers, to enhance lesion localization, maintain long-term site visibility, and improve diagnostic confidence. Multi-modality markers are specialized biopsy site markers designed to remain clearly visible across ultrasound, mammography, and MRI, allowing clinicians to accurately track biopsy sites and support precise follow-up assessments. For instance, in March 2024, Mammotome, a US-based medical technology company, launched LumiMARK, a next-generation 510(k)-cleared breast biopsy site marker for multi-modality identification. Offered in three distinct 3D shapes-including Tulip(TM) and Rose(TM)-the marker ensures consistent visibility across imaging modalities and provides enhanced long-term detectability in both breast tissue and lymph nodes, supporting more accurate diagnosis and ongoing clinical decision-making.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation

North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Localization Wires
  • 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
  • 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
  • 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
  • Subsegments:
  • 1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
  • 2) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
  • Companies Mentioned: Becton Dickinson and Company; Boston Scientific Corporation; Hologic Inc.; Cook Medical Inc.; Medtronic Plc; Olympus Corporation; B. Braun Melsungen AG; CONMED Corporation; FUJIFILM Holdings Corporation; Argon Medical Devices Inc.; SOMATEX Medical Technologies GmbH; TSK Laboratory Europe B.V.; INRAD Inc.; Esaote SpA; Planmed Oy; Canon Medical Systems Corporation; Siemens Healthineers; General Electric Company; Intuitive Surgical Inc.; Karl Storz SE And Co KG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Smart Biopsy Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Smart Biopsy Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Smart Biopsy Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Smart Biopsy Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Image-Guided Biopsy Systems
    • 4.2.2 Rising Use Of Robotic-Assisted Biopsy Procedures
    • 4.2.3 Growing Integration Of Real-Time Tissue Feedback Technologies
    • 4.2.4 Expansion Of Minimally Invasive Diagnostic Techniques
    • 4.2.5 Enhanced Focus On Diagnostic Accuracy And Patient Safety

5. Smart Biopsy Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic And Imaging Centers
  • 5.3 Academic And Research Institutes
  • 5.4 Oncology Specialty Clinics
  • 5.5 Ambulatory Surgical Centers

6. Smart Biopsy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Smart Biopsy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Smart Biopsy Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Smart Biopsy Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Smart Biopsy Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Smart Biopsy Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Smart Biopsy Devices Market Segmentation

  • 9.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle-Based Biopsy Instruments, Localization Wires
  • 9.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
  • 9.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
  • 9.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
  • 9.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
  • 9.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

10. Smart Biopsy Devices Market Regional And Country Analysis

  • 10.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Smart Biopsy Devices Market

  • 11.1. Asia-Pacific Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Smart Biopsy Devices Market

  • 12.1. China Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Smart Biopsy Devices Market

  • 13.1. India Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Smart Biopsy Devices Market

  • 14.1. Japan Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Smart Biopsy Devices Market

  • 15.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Smart Biopsy Devices Market

  • 16.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Smart Biopsy Devices Market

  • 17.1. South Korea Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Smart Biopsy Devices Market

  • 18.1. Taiwan Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Smart Biopsy Devices Market

  • 19.1. South East Asia Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Smart Biopsy Devices Market

  • 20.1. Western Europe Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Smart Biopsy Devices Market

  • 21.1. UK Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Smart Biopsy Devices Market

  • 22.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Smart Biopsy Devices Market

  • 23.1. France Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Smart Biopsy Devices Market

  • 24.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Smart Biopsy Devices Market

  • 25.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Smart Biopsy Devices Market

  • 26.1. Eastern Europe Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Smart Biopsy Devices Market

  • 27.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Smart Biopsy Devices Market

  • 28.1. North America Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Smart Biopsy Devices Market

  • 29.1. USA Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Smart Biopsy Devices Market

  • 30.1. Canada Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Smart Biopsy Devices Market

  • 31.1. South America Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Smart Biopsy Devices Market

  • 32.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Smart Biopsy Devices Market

  • 33.1. Middle East Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Smart Biopsy Devices Market

  • 34.1. Africa Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Smart Biopsy Devices Market Regulatory and Investment Landscape

36. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

  • 36.1. Smart Biopsy Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Smart Biopsy Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Smart Biopsy Devices Market Company Profiles
    • 36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Cook Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

37. Smart Biopsy Devices Market Other Major And Innovative Companies

  • Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG

38. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

40. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Smart Biopsy Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Smart Biopsy Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Smart Biopsy Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer